JPMorgan Upgrades Dr. Reddy's After Q2 Results
Dr. Reddy's shares climbed more than 5% on Monday, October 26, after the company reported better-than-expected second-quarter FY27 margins, while revenue and net profit declined year on year.
Shares of Dr. Reddy's Laboratories Ltd. climbed more than 5% on Monday, October 26, after the pharmaceutical company reported better-than-expected margins for the second quarter of FY27. While revenue and net profit declined year-on-year, a recovery in margins, new product launches and expectations…